Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator-Initiated, Use Study of Alefacept (Amevive) in Combination With Tapering Doses of Cyclosporine in Patients With Moderate to Severe Psoriasis

NCT00143806 is registered in ClinicalTrials.gov with University of Medicine and Dentistry of New Jersey as lead sponsor.

NCT NCT00143806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator-Initiated, Use Study of Alefacept (Amevive) in Combination With Tapering Doses of Cyclosporine in Patients With Moderate to Severe Psoriasis
Lead sponsor
University of Medicine and Dentistry of New Jersey
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
May 31, 2007
Enrollment
13
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis